Browse News
Filter News
Found 125 articles
-
Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results
4/22/2024
Nicox SA, an international ophthalmology company, provided the revenue and cash position for Nicox SA and its subsidiaries for the first quarter of 2024 and financial results for Nicox SA for the full year of 2023, as approved by the Board of Directors on April 19, 2024, and provided an update on key future milestones.
-
This is the latest rundown of people coming and going from executive positions at biopharma companies that BioSpace covers. This regular column highlights the hired, fired, retired, promoted or resigning, as well as those personally named in lawsuits.
-
Nicox Updates on Corporate, Pipeline and Financing Perspectives and Will Hold a Webcast on March 18, 2024
3/13/2024
Nicox SA, an international ophthalmology company, provided an update on its corporate and development strategy, in the context of its debt restructuring and the appointment of Gavin Spencer as Chief Executive Officer and announced it will be holding a Webcast on March 18, 2024 at 6:00 pm CET.
-
Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO
2/28/2024
Nicox SA, an international ophthalmology company, announced its Board of Directors has appointed the highly experienced biotech executive Gavin Spencer as Chief Executive Officer.
-
Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan
2/8/2024
Nicox SA announced the signature of an agreement granting Kowa Company, Ltd., a Japanese company with a global pharmaceutical business engaged in ground-breaking research, development and marketing, exclusive Japanese rights to develop and commercialize NCX 470, Nicox’s nitric oxide (NO)-donating bimatoprost eye drop, for the lowering of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
-
UPSHER-SMITH LAUNCHES PITAVASTATIN TABLETS
11/6/2023
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Pitavastatin Tablets in 1 mg, 2 mg, and 4 mg strengths.
-
Nonalcoholic Steatohepatitis (NASH) Market to Observe Stunning Growth by 2032 Owing to a Robust Pipeline
11/1/2023
The NASH market is expected to evolve because of emerging therapies like MGL-3196, Semaglutide, Vonafexor, HPG1860, VK2809, BIO89-100, LPCN 1144, and others.
-
Intermittent Claudication Market Current Perspective with Analysis of Leading Players Report By 2030
7/29/2022
Forecast to 2030,’ thoroughly examines the Intermittent Claudication industry to provide essential data & information for the targeted readers.
-
Prometheus completed its Phase II trial in UC, Algernon announced its Phase II trial of IPF and chronic coffee, Seelos dosed the first patient of SLS-005 for patients with ALS.
-
Lipid Disorder Treatment Market is Projected to Experience Promising Growth Opportunities in the Forthcoming Years
7/25/2022
Wilmington, Delaware, United States, Transparency Market Research Inc.: Emergence of various lifestyle diseases has been witnessed worldwide, especially among teens and people lying in the 50-60 years age group.
-
Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS®
7/19/2022
Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS ® (celecoxib 56-mg and tramadol hydrochloride 44mg)CI-V as an Efficacious Alternative for Moderate-to-Severe Acute Pain in Appropriate Patients.
-
U.S. Fundus Camera Market worth $ 191.80 Mn by 2030 at a CAGR of 4.9%
7/12/2022
According to Nova one advisor, the U.S. Fundus Camera market size was valued at US$ 130.16 Million in 2021 and is expected to hit US$ 191.80 Million by 2030, growing at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030.
-
Fundus Camera Market to Generate US$ 810.4 Million by 2028 | Growth & Key Business Strategies
6/13/2022
According to Transparency Market Research’s latest report on the global fundus camera market for the historical period, 2017–2019, and forecast period, 2021–2028, increase in geriatric population across the globe and surge in incidence of retinal disorders are projected to drive the global fundus camera market during the forecast period
-
Diabetic Retinopathy Market Insights, Future Trends, On-going Demand, Opportunities, Segmentation, and Forecast Till 2028
5/23/2022
Rising prevalence of diabetes and increasing incidences of blindness among people with severe diabetic conditions are expected to fuel the global market growth
-
Growing Prevalence of Cardiovascular Diseases Positions Dyslipidemia Therapeutics Market to Surpass US$ 36 Bn
12/15/2021
Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global dyslipidemia therapeutics market is projected to experience substantial growth through 2028.
-
Dyslipidemia Therapeutics Market: Competitive Analysis and Key Developments
7/14/2021
Dyslipidemia, a key risk factor for cardiovascular disease, poses high health burden to the developed world, thus, propelling the need for effective therapies that are well tolerated.
-
Diabetic Retinopathy Market Size to Reach USD 15.01 Billion in 2028
7/1/2021
Rising prevalence of diabetes and increasing incidences of blindness among people with severe diabetic conditions are expected to fuel the global market growth.
-
Medical Masks Sales on Rise with Growing Number of Surgeries and Rising Infectious Diseases: Fact.MR
5/10/2021
Owing to the new product launches and development of new plants for the production of medical masks, North America and Europe holds 50% of global market share
-
ESTEVE and KOWA Pharmaceuticals America enter into an Exclusive License and Commercialization Agreement for rights to E-58425 for the potential management of acute pain(1-9) in the United States(8,9)
5/3/2021
Esteve Pharmaceuticals (ESTEVE), an international specialty pharmaceutical company devoted to the development and commercialization of innovative products, today announced an agreement with Kowa Pharmaceuticals America, Inc.
-
Disposable Face Mask Market | Know the Current Market Scenario with Forecast by 2029
4/28/2021
Disposable face masks are witnessing higher demand for themselves in current times because of the COVID-19 pandemic. These products are used to protect the face and nose from contamination.